Towards quorum-quenching catalytic antibodies†
Abstract
The development of a novel method to attenuate bacterial virulence is reported, which is based upon the use of designed transition-state analogues to select human catalytic
* Corresponding authors
a
Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK
E-mail:
drspring@ch.cam.ac.uk
b Department of Biochemistry, University of Cambridge, Cambridge, UK
The development of a novel method to attenuate bacterial virulence is reported, which is based upon the use of designed transition-state analogues to select human catalytic
P. B. Kapadnis, E. Hall, M. Ramstedt, W. R. J. D. Galloway, M. Welch and D. R. Spring, Chem. Commun., 2009, 538 DOI: 10.1039/B819819E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content